DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
MLPSX
Price
$103.34
Change
-$0.25 (-0.24%)
Updated
Jul 31 closing price
Net Assets
2.72M
Interact to see
Advertisement

DFSVX vs MLPSX

DFSVX vs MLPSX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. MLPSX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and MLPSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. MLPSX (2.72M). DFSVX pays higher dividends than MLPSX: DFSVX (1.50) vs MLPSX (0.00). DFSVX was incepted earlier than MLPSX: DFSVX (33 years) vs MLPSX (25 years). MLPSX (3.15) is less costly to investors than DFSVX (0.31). MLPSX is a more actively managed with annual turnover of: 988.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than MLPSX: DFSVX (0) vs MLPSX (15000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. MLPSX (17.59). DFSVX return over 5 years is better than : 50.66 vs. MLPSX (33.55).
DFSVXMLPSXDFSVX / MLPSX
Total Expense Ratio0.312.7811%
Annual Report Gross Expense Ratio0.313.1510%
Fund Existence33 years25 years-
Gain YTD21.33611.370188%
Front LoadN/AN/A-
Min. Initial Investment015000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B2.72M716,648%
Annual Yield % from dividends1.500.00-
Returns for 1 year34.3917.59195%
Returns for 3 years50.3729.11173%
Returns for 5 years50.6633.55151%
Returns for 10 years107.7175.21143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I